1 unchanged sentence
Market Information
−Removed: Our common stock began trading on the Australian Securities Exchange under the symbol “360” on May 10, 2019.
−Removed: Prior to that time, there was no public market for our common stock.
+Added: Our CDIs began trading on the Australian Securities Exchange under the symbol “360” on May 10, 2019.
+Added: On June 6, 2024, our common stock began trading on The Nasdaq Stock Market under the symbol “LIF.”
Holders of Record
7 unchanged sentences
Performance Graph
−Removed: The following performance graph shows a comparison of the change in the cumulative total return for our common stock, the S&P 500 Index, and the ASX 200 Index between June 30, 2019, the first quarter end after our common stock commenced trading on the Australian Securities Exchange on May 10, 2019, and December 31, 2023.
−Removed: All values assume an initial investment of $100 and reinvestment of any dividends.
+Added: The following performance graph shows a comparison of the change in the cumulative total return for our common stock, the S&P 500 Index, and the ASX 200 Index.
+Added: The graph assumes $100 was invested (with reinvestment of all dividends, as applicable) at the close of market on December 31, 2019.
+Added: The value of our common stock prior to our June 2024 U.S.
+Added: IPO is based on the closing price per share of our common stock on the ASX and the daily exchange rate as reported by Tullett Prebon for conversion of Australian dollars into U.S.
+Added: The value of our common stock subsequent to our June 2024 U.S.
+Added: IPO is based on the closing price per share of our common stock as reported by Nasdaq Stock Market LLC.
+Added: All values and are presented in USD.
The comparisons are based on historical data and are not indicative of, nor intended to forecast, the future performance of our common stock.
−Removed: The information presented within the graph above is presented in USD.
−Removed: The USD value of our common stock is equivalent to the CDI value (the AUD value of our common stock traded on the Australian Securities Exchange) multiplied by 3 (CDI conversion ratio) and then multiplied by the applicable foreign currency exchange rate between the USD and the AUD for the applicable period.
Recent Sales of Unregistered Equity Securities
+Added: During the twelve months ended December 31, 2024, holders of the July 2021 Convertible Notes elected to convert their outstanding notes and accrued interest to shares of common stock based on a fixed conversion price of $11.96 per share.
+Added: The holders of the July 2021 Convertible Notes also elected to exercise their outstanding warrants which were issued in connection with the July 2021 Convertible Notes at an exercise price of $11.96 per share.
+Added: As a result of the conversion of the notes and the exercise of warrants, we issued 184,192 and 88,212 shares, respectively, of common stock to the holders.
+Added: Refer to Note 8, "Convertible Notes" for further details.
+Added: During the twelve months ended December 31, 2024, holders of the September 2021 Convertible Notes elected to convert their outstanding notes and accrued interest to shares of common stock based on a fixed conversion price of $22.50 per share.
+Added: As a result of the conversion of the notes, we issued 157,685 shares of common stock to the holders.
+Added: Refer to Note 8, "Convertible Notes" for further details.
+Added: We relied on an exemption from registration provided by 4(a)(2) of the Securities Act of 1933, as amended, for the issuance of the shares described above as transactions by an issuer not involving a public offering.
+Added: Use of Proceeds
+Added: On June 6, 2024, we completed our U.S.
+Added: IPO, in which we issued and sold 3,703,704 shares of common stock and certain selling securityholders sold 2,908,796 shares of common stock (including 862,500 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares) at an offering price of $27.00 per share.
+Added: We received net proceeds of $79.9 million after deducting underwriting discounts and commissions of $7.0 million and total other offering related expenses payable by us of approximately $13.1 million.
+Added: Other offering related expenses included on the consolidated statement of operations and comprehensive loss of $6.8 million includes a $5.5 million payment to selling securityholders for certain of their expenses in connection with the offering, including all underwriting discounts and commissions applicable to the sale of shares of common stock by the selling securityholders, including to certain executive officers, members of the board of directors, non-executive employees, and other related parties.
+Added: We did not receive any proceeds from the sale of shares by the selling securityholders.
+Added: All shares sold were registered pursuant to an automatically effective registration statement on Form S-3 (File No.
+Added: 333-279271) filed with the SEC on May 9, 2024 (the “Registration Statement”).
+Added: There has been no material change in the expected use of the net proceeds from our U.S.
+Added: IPO as described in our final prospectus supplement filed as part of the Registration Statement.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.